Related Experiment Videos
[Transient subendocardial ischemia in abolition of hypertensive crises with nifedipine]
Insights
Sublingual nifedipine effectively treated hypertensive crises, improving cardiac function and ejection fraction. Some patients experienced transient ECG changes, but no clinical signs of myocardial ischemia were observed.
Area of Science:
- Cardiology
- Pharmacology
Abstract:
Sublingual nifedipine, 30 mg, was used to abolish hypertensive crises in 32 patients. A follow-up of changes in blood pressure, ECG, and echocardiographic parameters evaluating the cardiac performance and central hemodynamics was performed during 4 hours after the drug. The patients with profound myocardial hypertrophy and dilatation at a left ventricular myocardial weight of over 200 g at the peak of the antihypertensive effect occurred for 15-60 min exhibited transient ECG changes by the type of subendocardial ischemia despite an above 25% reduction in mean blood pressure and the lack of severe reflex tachycardia, the pump function of the heart showing no decreases. The ejection fraction increased from 51.0 +/- 2.8 to 62.0 +/- 2.5% (p less than 0.05) due to lower afterload. There were no clinical manifestations typical of myocardial ischemia.